How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 4, 1998, Pages 419-426

  Khan, Mahbub H ^a,b   Thomas, Liza ^a,b   Byth, Karen ^a,b   Kench, James ^b   Weltman, Martin ^a,b   George, Jacob ^a,b   Liddle, Christopher ^a,b   Farrell, Geoffrey C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Alcohol; Hepatic fibrosis; Hepatitis C; Injection drug use; Natural history; Quantitative histology; Toxic threshold

Indexed keywords

ALCOHOL;

ADULT; AGING; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031955406     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00657.x     Document Type: Article

References (39)

1. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long term clinical and histopathological follow-up of chronic post transfusion hepatitis. Hepatology 1991; 14: 969-74.
2. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993; 34(Suppl. 2): S13-16.
3. Realdi G, Alberti A, Rugge M et al. Long term follow-up of acute and chronic non-A non-B post transfusion hepatitis: evidence of progression to liver cirrhosis. Gut 1982; 23: 270-5.
4. Delladetsima JK, Rassidakis G, Tassopoulos NC, Papatheodoridis GV, Smyrnoff T, Vatiadis I. Histopathology of chronic hepatitis C in relation to epidemiological factors. J. Hepatol. 1996; 24: 27-32.
5. Strasser SI, Watson JR, Lee CS, Coghlan PJ, Desmond PV. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med. J. Aust. 1995; 62: 355-8.
6. Gordon SC, Elloway RS, Long JC, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: Blood transfusion versus intravenous drug use. Hepatology 1993; 18: 1338-43.
7. Watson JP, Brind AM, Chapman CE et al. Hepatitis C virus: epidemiology and genotypes in north east of England. Gut 1996; 38: 269-76.
8. Dusheiko G, Schmilovitz-Weiss H, Brown D et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13-18.
9. Gordon SC, Kodali VP, Silverman AL et al. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am. J. Gastroenterol. 1994; 89: 1458-61.
10. Weltman MD, Brotodihardjo A, Crewe EB et al. Coinfection with hepatitis B and C, or B, C, and D viruses results in severe chronic liver disease and responds poorly to interferon-α treatment. J. Viral Hepat. 1995; 2: 39-45.
11. Caldwell SH, Li X, Rourk RM et al. Hepatitis C infection by polymerase chain reaction in alcoholics; false-positive ELISA results and influence of infection on a clinical prognostic score. Am. J. Gastroenterol. 1993; 88: 1016-21.
12. Pares A, Barrera JM, Caballeria J et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990; 12: 1295-9.
13. Mendenhall CL, Seeff L, Diehl AM et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 1991; 14: 581-9.
14. Nalpas B, Thiers V, Pol S et al. Hepatitis C viraemia and anti-HCV antibodies in alcoholics. J. Hepatol. 1992; 14: 381-4.
15. Fukiozumi K, Sata M, Ishii K, Kumashiro R, Tanikawa K. Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver disease. Hepatology 1994; 20: 349A.
16. Nishiguchi S, Kuroki T, Yabusako T et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991; 14: 985-9.
17. Cooksley WGE. Chronic liver disease: Do alcohol and hepatitis C virus interact? J. Gastroenterol. Hepatol. 1996; 11: 187-92.
18. Rosman AS, Paronetto F, Galvin K, Williams RJ, Lieber CS. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and or lobular hepatitis. Arch. Intern. Med. 1993; 153: 965-9.
19. FongT-L, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994; 19: 554-7.
20. Oshita M, Hayashi N, Kasahara A et al. Increased serum hepatitis C virus levels amongst alcoholic patients in patients with chronic hepatitis C. Hepatology 1994; 20: 1115-20.
21. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: Effects of alcohol on hepatitic activity and viral titer. J. Hepatol. 1996; 25: 821-6.
22. Takase S, Matsuda Y, Sawada M, Takada N, Takada A. Effect of alcohol abuse on HCV replication. Gastroenterologica Japonica 1993; 28: 322.
23. Alemy-Carreau M, Durbec JP, Giordanella J et al. Lack of interaction between hepatitis C virus and alcohol in the pathogenesis of cirrhosis. A statistical study. J. Hepatol. 1996; 25: 627-32.
24. Lin R, Roach E, Zimmerman M, Strasser S, Farrell GC for the Australian Hepatitis C Study Group. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. J. Hepatol. 1995; 23: 487-96.
25. Lin R, Schoeman MN, Bilous M et al. Can response to Interferon treatment be predicted in patients with chronic active hepatitis C? Aust. NZ J. Med. 1991; 21: 387-92.
26. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J. Hepatol. 1991; 13: 372-4.
27. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987.
28. Gebski V, Leung O, McNeil D, Lunn D. SPIDA User's manual, version 6. Sydney: Statistical Computing Laboratory, 1992.
29. Poynard T, Bedossa P, Opolon P et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
30. Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995; 15: 300-6.
31. Yano M, Kumada H, Kage M et al. The long term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
32. Selvey L, Srirajalingam M, Crawford D, Cooksley WGE. Alcohol does not play a significant role in promoting cirrhosis in chronic hepatitis C: analysis of 102 patients. In: Round table conference: Alcohol and Viruses. Surfers Paradise: International Society for Biomedical Research in Alcoholism, 1994.
33. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M. Long-term evolution of fibrosis from chronic-hepatitis to cirrhosis in patients with chronic hepatitis C: morphometric analysis of repeated biopsies. Hepatology 1997; 25: 1028-31.
34. Shiomi S, Kuroki T, Minamitani S et al. Effect of drinking on outcome of cirrhosis in patients with hepatitis B or C. J. Gastroenterol. Hepatol. 1992; 7: 274-6.
35. Levy LT, Chen JJ, McGuinness PH, Koorey D, Shiel AGR, McCaughan GW. Liver transplantation for hepatitis C associated cirrhosis in a single Australian Centre: Referral patterns and transplant outcomes. J. Gastroenterol. Hepatol. 1997; 12: 453-9.
36. Simmonds P, Mellor J, Craxi A et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J. Hepatol. 1996; 24: 517-24.
37. Silini E, Bono F, Cividini A et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J. Hepatol. 1995; 22: 691-5.
38. Lin R, Liddle C, Byth K, Farrell GC. Virus and host factors are both important determinants of response to Interferon treatment among patients with chronic hepatitis C. J. Viral Hepat. 1996; 3: 85-96.
39. Chiaramonte M, Stroffolini T, Lorenzoni U et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J. Hepatol. 1996; 24: 129-34.